The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
A prospective study of obesity and cancer risk (Sweden)
Abstract
Objective [corrected] We evaluated the relation between obesity and the risks for various forms of cancer.Methods In a population-based cohort of 28,129 hospital patients (8165 men, 19,964 women) with any discharge diagnosis of obesity (9557 only diagnosis, 5266 primary, 13,306 secondary) during 1965-1993, cancer incidence was ascertained through 1993 by record linkage to the nationwide Swedish Cancer Registry. Cancer risk was estimated using the standardized incidence ratio (SIR, with 95% confidence interval), which is the ratio of the observed number of cancers to that expected.Results Overall, a 33% excess incidence of cancer was seen in obese persons, 25% in men and 37% in women. Significant risk elevations were observed for cancers of the small intestine (SIR = 2.8; 95% CI 1.6-4.5), colon (1.3; 1.1-1.5), gallbladder (1.6; 1.1-2.3), pancreas (1.5; 1.1-1.9), larynx (2.1; 1.1-3.5), renal parenchyma (2.3; 1.8-2.8), bladder (1.2; 1.0-1.6), cervix uteri (1.4; 1.1-1.9), endometrium (2.9; 2.5-3.4), ovary (1.2; 1.1-1.5), brain (1.5; 1.2-1.9), and connective tissue (1.9; 1.1-3.0), and for lymphomas (1.4; 1.0-1.7), with higher risk observed for Hodgkin's disease only in men (3.3; 1.4-6.5) and for non-Hodgkin's lymphoma only in women (1.6; 1.2-2.1). The association of obesity with risk of breast, prostate and pancreas cancers was modified by age.Conclusions Obesity is associated with more forms of cancer than previously reported.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“whilst both older males and females are at increased risk of hepatobiliary (gallbladder and pancreatic), and genitourinary (renal, bladder, uterine, cervical and prostate) cancers [33].”
From Obesity pharmacotherapy in older adults: a narrative review of evidence (2025) · cites this paper as [33]
Citations
Cites
Overweight and obesity in the United States: prevalence and trends, 1960–1994
Flegal, K., Carroll, M., Kuczmarski, R., & Johnson, C. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800541 · Cited by 3,045
Energy and protein requirements*
Pacey, A., & Payne, P. (2019) · Routledge eBooks · doi:10.4324/9780429036279-4 · Cited by 2,545
Body Weight and Mortality among Women
Manson, J. E., Willett, W. C., Stampfer, M. J., Colditz, G. A., Hunter, D. J., Hankinson, S. E., Hennekens, C. H., & Speizer, F. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509143331101 · Cited by 2,005
Limitations of the Application of Fourfold Table Analysis to Hospital Data
Berkson, J. (1946) · Biometrics Bulletin · doi:10.2307/3002000 · Cited by 1,810 · cited 1×
“Another concern in linked-registry studies is the possibility of confounding by associated conditions such as alcoholism, diabetes or other unmeasured factors in a cohort of hospitalized subjects [42].”
BackgroundA Prospective Study of Obesity and Risk of Coronary Heart Disease in Women
Manson, J. E., Colditz, G. A., Stampfer, M. J., Willett, W. C., ROSNER, B. A., Monson, R. R., Speizer, F. E., & Hennekens, C. H. (1990) · New England Journal of Medicine · doi:10.1056/nejm199003293221303 · Cited by 1,403
The design and analysis of cohort studies
Breslow, N. E., & Day, N. E. (1987) · International Agency for Research on Cancer eBooks · Cited by 1,312
Variations in mortality by weight among 750,000 men and women
Lew, E. A., & Garfinkel, L. (1979) · Journal of Chronic Diseases · doi:10.1016/0021-9681(79)90119-x · Cited by 1,169
Weight, Weight Change, and Coronary Heart Disease in Women: Risk Within the 'Normal' Weight Range
Willett, W. C. (1995) · JAMA · doi:10.1001/jama.1995.03520300035033 · Cited by 924
Increased cell division as a cause of human cancer.
Preston‐Martin, S., Pike, M. C., Ross, R. K., Jones, P. A., & Henderson, B. E. (1990) · PubMed · Cited by 896
Colorectal Cancer: Molecules and Populations
Potter, J. D. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.11.916 · Cited by 876
Flagged first, then by citations
Research works printed but not linked: 6
- Mattson B, Wallgren A (1984) Completeness of the Swedish Cancer Registry. Acta Radiol 23: 305-313.
- The Cancer Registry (1995) Cancer Incidence in Sweden 1980 (and 1993) (annual publications). Stockholm: National Board of Health and Welfare.
- Fraumeni JF Jr, Devesa SS, McLaughlin JF, Stanford JL (1996) Biliary tract cancer. In: Schottenfield D, Fraumeni JJF, eds. Cancer Epidemiology and Prevention. Oxford: Oxford University Press, pp. 794-805.
- Ji BT, Hatch MC, Chow WH, et al. (1996) Anthropometric and reproductive factors and the risk of pancreatic cancer: a case-control study in Shanghai, China. Int J Cancer 66: 32-37.
- Flyvbjerg A, Orskov H (1990) Growth hormone, insulin-like growth factors and diabetes. In: Alberti KGMM, Krall LP, eds, The Diabetes Annual 5. Amsterdam: Elsevier, pp. 642-656.
- Hotzel D (1986) Suboptimal nutritional status in obesity. Bibl Nutr Dieta 37: 36-41.
Cited by
Sorted by citations
Items 201–300 of 584
Genome-wide interaction study of smoking and bladder cancer risk
Figueroa, J. D., Han, S. S., García‐Closas, M., Baris, D., Jacobs, E. J., Kogevinas, M., Schwenn, M. R., Malats, N., Johnson, A. T., Purdue, M. P., et al. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu064 · Cited by 64
Self-citationFor the Women's Health Initiative Investigators, Luo, J., Margolis, K. L., Adami, H., LaCroix, A. Z., & Ye, W. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604487 · Cited by 63
Self-citationLiver Transplantation in Patients With Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma
Malik, S. M., Gupte, P., de Vera, M. E., & Ahmad, J. E. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.02.025 · Cited by 63
Hafron, J. M., Mitra, N., Dalbagni, G. M., Bochner, B. H., Herr, H. W., & Donat, S. M. (2005) · The Journal of Urology · doi:10.1097/01.ju.0000154352.54965.14 · Cited by 62
Anthropometric factors and risk of melanoma in women: A pooled analysis
Olsen, C. M., Green, A. C., Zens, M. S., Stukel, T. A., Bataille, V. A., Berwick, M., Elwood, M., Gallagher, R. P., Holly, E. A., Kirkpatrick, C., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.23214 · Cited by 62
Body Size and Composition and the Risk of Lymphohematopoietic Malignancies
MacInnis, R. J., English, D. R., Hopper, J. L., & Giles, G. G. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji209 · Cited by 62
Circulating Adiponectin and Leptin in Relation to Myelodysplastic Syndrome: A Case-Control Study
Dalamaga, Μ., Nikolaidou, A., Καρμανιώλας, Κ., Hsi, A., Chamberland, J. P., Dionyssiou‐Asteriou, A., & Mantzoros, C. S. (2007) · Oncology · doi:10.1159/000120995 · Cited by 61
Modesitt, S. C., Tian, C., Kryscio, R. J., Thigpen, J. T., Randall, M. E., Gallion, H. H., & Fleming, G. F. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.10.045 · Cited by 61
Li, L., Gan, Y., Li, W., Wu, C., & Lu, Z. (2016) · Obesity · doi:10.1002/oby.21505 · Cited by 61
Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome
Rahimi, R. S., & Landaverde, C. E. (2013) · Nutrition in Clinical Practice · doi:10.1177/0884533612470464 · Cited by 60
Pathways and targets in hepatocellular carcinoma
Psyrri, A. K., Arkadopoulos, N. F., Vassilakopoulou, M., Smyrniotis, V. E., & Dimitriadis, G. (2012) · Expert Review of Anticancer Therapy · doi:10.1586/era.12.113 · Cited by 60
Validity of ICD-10 diagnoses of overweight and obesity in Danish hospitals
Gribsholt, S. B., Pedersen, L. H., Richelsen, B., & Thomsen, R. W. (2019) · Clinical Epidemiology · doi:10.2147/clep.s214909 · Cited by 60
Hasselgren, P.-O. J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90965-5.00007-6 · Cited by 60
Anthropometric measures and risk of cutaneous malignant melanoma: a case–control study from Italy
Gallus, S., Naldi, L., Martin, L., & Martinelli, M. (2006) · Melanoma Research · doi:10.1097/01.cmr.0000194429.77643.76 · Cited by 60
Leptin in hepatocellular carcinoma
Wang, S.-N. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i46.5801 · Cited by 59
International trends in primary liver cancer incidence from 1973 to 2007
Zhang, Y., Ren, J., Shi, J., Li, N., Wang, Y., Qu, C., Zhang, Y., & Dai, M. (2015) · BMC Cancer · doi:10.1186/s12885-015-1113-4 · Cited by 59
Potential role of leptin expression in hepatocellular carcinoma
Wang, S.-N., Yeh, Y.-T., Yang, S., Chai, C.-Y., & Lee, K.-T. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.035477 · Cited by 59
Birds and longevity: Does flight driven aerobicity provide an oxidative sink?
Hickey, A. J., Jüllig, M., Aitken, J. F., Loomes, K. M., Hauber, M. E., & Phillips, A. R. J. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2011.12.002 · Cited by 59
Causes of and Prevention Strategies for Hepatocellular Carcinoma
Cabibbo, G., Maida, M. F., Genco, C., Antonucci, M., & Cammà, C. (2012) · Seminars in Oncology · doi:10.1053/j.seminoncol.2012.05.006 · Cited by 58
Rogozina, O. P., Bonorden, M. J. L., Seppanen, C. N., Grande, J. P., & Cleary, M. P. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0140 · Cited by 58
The role of adiponectin in obesity-associated female-specific carcinogenesis
Nagaraju, G. P., Rajitha, B., Aliya, S., Kotipatruni, R. P., Santharam, M. A., Hammond, A. L., Park, D., Chigurupati, S., Alam, A., & Pattnaik, S. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.03.014 · Cited by 58
Campbell, P. T., Newton, C. C., Kitahara, C. M., Patel, A. V., Hartge, P. A., Koshiol, J. E., McGlynn, K. A., Adami, H., de González, A. B., Freeman, L. E. B., et al. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0796 · Cited by 58
Self-citationThe association between BMI and gallbladder cancer risk: A meta-analysis
Li, Z.-M., Wu, Z.-X., Han, B., Mao, Y.-Q., Chen, H.-L., Han, S.-F., Xia, J.-L., & Wang, L.-S. (2016) · Oncotarget · doi:10.18632/oncotarget.9664 · Cited by 57
Cancer morbidity of professional emergency responders in Korea
Ahn, Y., Jeong, K., & Kim, K. (2012) · American Journal of Industrial Medicine · doi:10.1002/ajim.22068 · Cited by 57
Lukanova, A., Lundin, E., Micheli, A., Akhmedkhanov, A., Rinaldi, S., Muti, P., Lenner, P., Biessy, C., Krogh, V., Ríboli, E., et al. (2003) · Cancer Causes & Control · doi:10.1023/a:1023688603547 · Cited by 56
Association between metabolic abnormalities and hepatitis C-related hepatocellular carcinoma
Khattab, M. A., Eslam, M., Mousa, Y. I., Ela-adawy, N., Fathy, S., Shatat, M., Abd-Aalhalim, H., Kamal, A., & Sharawe, M. A. (2012) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31462-0 · Cited by 56
Statins and the risk of gastric cancer in diabetes patients
Lee, J., Lee, S. H., Hur, K. Y., Woo, S., Kim, S.-W., & Kang, W. K. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-596 · Cited by 56
Preziosi, G., Oben, J. A., & Fusai, G. (2014) · Surgical Oncology · doi:10.1016/j.suronc.2014.02.003 · Cited by 55
Habeeb, B. S., Kitayama, J., & Nagawa, H. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01902.x · Cited by 55
Dalamaga, Μ., Καρμανιώλας, Κ., Nikolaidou, A., Chamberland, J. P., Hsi, A., Dionyssiou‐Asteriou, A., & Mantzoros, C. S. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.04.015 · Cited by 55
Torres, M. C. P., Bodini, G., Furnari, M., Marabotto, E., Zentilin, P., Strazzabosco, M., & Giannini, E. G. (2020) · Cancers · doi:10.3390/cancers12061422 · Cited by 54
Eberle, C. A., Bracci, P. M., & Holly, E. A. (2005) · Cancer Causes & Control · doi:10.1007/s10552-005-0354-y · Cited by 54
Madkan, V. K., Cook‐Norris, R. H., Steadman, M. C., Arora, A., Mendoza, N., & Tyring, S. K. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.07961.x · Cited by 53
Overweight, Obesity and Meningioma Risk: A Meta-Analysis
Shao, C., Bai, L.-P., Qi, Z., Hui, G., & Wang, Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090167 · Cited by 53
Inoue, M., Kurahashi, N., Iwasaki, M., Tanaka, Y., Mizokami, M., Noda, M., & Tsugane, S. (2008) · Cancer Causes & Control · doi:10.1007/s10552-008-9287-6 · Cited by 52
Maskarinec, G., Erber, E., Gill, J. K., Cozen, W., & Kolonel, L. N. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0716 · Cited by 52
Ande, S. R., Nguyen, K. H., Nyomba, B. L. G., & Mishra, S. (2016) · Scientific Reports · doi:10.1038/srep23608 · Cited by 52
Causes of death in obesity: Relevant increase in cardiovascular but not in all-cancer mortality
Bender, R., Zeeb, H., Schwarz, M., Jöckel, K., & Berger, M. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2006.01.006 · Cited by 52
Obesity pharmacotherapy in older adults: a narrative review of evidence
Henney, A. E., Wilding, J. P. H., Alam, U., & Cuthbertson, D. J. (2025) · International Journal of Obesity · doi:10.1038/s41366-024-01529-z · Cited by 51
Trevellin, E., Scarpa, M., Carraro, A., Lunardi, F., Kotsafti, A., Porzionato, A., Saadeh, L. M., Cagol, M., Alfieri, R., Tedeschi, U., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3587 · Cited by 51
Cytokine polymorphisms in Th1/Th2 pathway genes, body mass index, and risk of non-Hodgkin lymphoma
Chen, Y., Zheng, T., Lan, Q., Foss, F. M., Kim, C., Chen, X., Dai, M., Li, Y., Holford, T. R., Leaderer, B. P., et al. (2010) · Blood · doi:10.1182/blood-2010-07-295097 · Cited by 51
Obesity and the risk of cholangiocarcinoma: a meta-analysis
Li, J.-S., Han, T., Jing, N., Li, L., Zhang, X., Ma, F.-Z., & Liu, J. (2014) · Tumor Biology · doi:10.1007/s13277-014-1939-4 · Cited by 50
Lu, Y., Prescott, J., Sullivan‐Halley, J., Henderson, K. D., Ma, H., Chang, E. T., Clarke, C. A., Horn‐Ross, P. L., Ursin, G., & Bernstein, L. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp268 · Cited by 50
Epidemiology and Risk Factors of Biliary Tract and Primary Liver Tumors
Augustine, M. M., & Fong, Y. (2013) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2013.10.001 · Cited by 49
Body size and the risk of biliary tract cancer: a population-based study in China
Hsing, A. W., Sakoda, L. C., Rashid, A., Chen, J., Shen, M., Han, T. Q., Wang, B. S., & Gao, Y. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604616 · Cited by 49
Adipocytokines and squamous cell carcinoma of the esophagus
Nakajima, T. E., Yamada, Y., Hamano, T., Furuta, K., Oda, I., Kato, H., Kato, K., Hamaguchi, T., & Shimada, Y. (2009) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-009-0657-6 · Cited by 48
Metabolic risk factors and skin cancer in the Metabolic Syndrome and Cancer Project (Me-Can)
Nagel, G., Bjørge, T., Stocks, T., Manjer, J., Hallmans, G., Edlinger, M., Häggström, C., Engeland, A., Johansen, D., Kleiner, A., et al. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.10974.x · Cited by 48
Central adiposity as a major risk factor of ovarian cancer.
Delort, L., Kwiatkowski, F., Chalabi, N., Satih, S., Bignon, Y., & Bernard-Gallon, D. J. (2009) · PubMed · Cited by 48
Psaltopoulou, T., Sergentanis, T. N., Ntanasis‐Stathopoulos, I., Tzanninis, I., Riza, E., & Dimopoulos, M. A. (2019) · International Journal of Cancer · doi:10.1002/ijc.32109 · Cited by 47
Lindkvist, B., Almquist, M., Bjørge, T., Stocks, T., Borena, W., Johansen, D., Hallmans, G., Engeland, A., Nagel, G., Jönsson, H., et al. (2012) · Cancer Causes & Control · doi:10.1007/s10552-012-0096-6 · Cited by 47
Metabolic risk factors of ovarian cancer: a review
Khanlarkhani, N., Azizi, E., Amidi, F., Khodarahmian, M., Salehi, E., Pazhohan, A., Farhood, B., Mortezaee, K., Goradel, N. H., & Nashtaei, M. S. (2021) · JBRA · doi:10.5935/1518-0557.20210067 · Cited by 46
Rui, R., Lou, J., Zou, L., Zhong, R., Wang, J., Ding, X., Wang, Q., Li, H., Wu, J., Lu, X., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044522 · Cited by 46
Kabat, G. C., Kim, M., Jean-Wactawski-Wende, Bea, J. W., Edlefsen, K. L., Adams-Campbell, L. L., Roos, A. J. D., & Rohan, T. E. (2011) · Cancer Epidemiology · doi:10.1016/j.canep.2011.05.014 · Cited by 46
Associations between Adiponectin and Two Different Cancers: Breast and Colon
Gülçelik, M. A., Çolakoğlu, M. K., Dincer, H., Doğan, L., Yenidoğan, E., & Gülçelik, N. E. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.1.395 · Cited by 45
Muriel, P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804274-8.00001-1 · Cited by 45
Role of adiponectin in obesity related gastrointestinal carcinogenesis
Nagaraju, G. P., Aliya, S., & Alese, O. B. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.06.007 · Cited by 45
DNA repair gene ERCC2 polymorphisms and associations with breast and ovarian cancer risk
Bernard-Gallon, D. J., Bosviel, R., Delort, L., Fontana, L., Chamoux, A., Rabiau, N., Kwiatkowski, F., Chalabi, N., Satih, S., & Bignon, Y. (2008) · Molecular Cancer · doi:10.1186/1476-4598-7-36 · Cited by 45
Than, N. N., Ghazanfar, A., Hodson, J. A., Tehami, N., Coldham, C., Mergental, H., Manas, D., Shah, T., Newsome, P. N., Reeves, H. L., et al. (2016) · QJM · doi:10.1093/qjmed/hcw151 · Cited by 45
Boffetta, P., Hazelton, W. D., Chen, Y., Sinha, R. R., Inoue, M., Gao, Y. T., Koh, W., Shu, X. O., Grant, E. J., Tsuji, I., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr562 · Cited by 44
Body mass index and cancer incidence: the FINRISK study
Song, X., Pukkala, ., Dyba, T. A., Tuomilehto, J., Moltchanov, V., Männistö, S., Jousilahti, P., & Qiao, Q. (2014) · European Journal of Epidemiology · doi:10.1007/s10654-014-9934-z · Cited by 44
Tobacco use, body mass index and the risk of malignantlymphomas—A nationwide cohort study in Sweden
Fernberg, P., Odenbro, Å., Bellocco, R., Boffetta, P., Yudi Pawitan, Y., & Adami, J. (2005) · International Journal of Cancer · doi:10.1002/ijc.21617 · Cited by 44
Tan, W., Gao, M., Liu, N., Zhang, G., Xu, T., & Cui, W. (2015) · Nutrients · doi:10.3390/nu7105387 · Cited by 44
Obesity and Pancreatic Cancer: Overall Evidence and Latency Period
Michaud, D. S., & Fuchs, C. S. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0428 · Cited by 44
Maurer, T., Maurer, J., Retz, M. M., Paul, R., Zantl, N., Gschwend, J. E., & Treiber, U. (2009) · Urologia Internationalis · doi:10.1159/000218533 · Cited by 43
van Veldhoven, K., Khan, A. E., Teucher, B., Rohrmann, S., Raaschou‐Nielsen, O., Tjønneland, A. M., Overvad, K., Vigl, M., Boeing, H., Benetou, V., et al. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.11.010 · Cited by 43
Functional roles of GDF15 in modulating microenvironment to promote carcinogenesis
Rochette, L., Méloux, A., Zeller, M., Cottin, Y., & Vergely, C. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165798 · Cited by 43
Microbiota and nonalcoholic steatohepatitis
Imajo, K., Yoneda, M., Ogawa, Y., Wada, K., & Nakajima, A. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0404-6 · Cited by 42
Energy balance feasibility study for Latinas in Texas: a qualitative assessment.
Ramírez, A. G., Chalela, P., Gallion, K. J., & Vélez, L. F. (2007) · PubMed Central · Cited by 42
Hillenbrand, A., Fassler, J., Huber, N., Xu, P., Henne‐Bruns, D., Templin, M. F., Schrezenmeier, H., Wolf, A. M., & Knippschild, U. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-545 · Cited by 41
Obesity and risk of non-Hodgkin lymphoma (United States)
Chiu, B. C. ‐., Soni, L. K., Gapstur, S. M., Fought, A. J., Evens, A. M., & Weisenburger, D. D. (2007) · Cancer Causes & Control · doi:10.1007/s10552-007-9013-9 · Cited by 41
Schrader, A. J., Rustemeier, J., Rustemeier, J. C., Timmesfeld, N., Varga, Z., Hegele, A., Olbert, P. J., & Hofmann, R. W. (2009) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-009-0616-2 · Cited by 41
A review of body size and breast cancer risk in Hispanic and African American women
Sexton, K. R., Franzini, L., Day, R. S., Brewster, A. M., Vernon, S. W., & Bondy, M. L. (2011) · Cancer · doi:10.1002/cncr.26217 · Cited by 39
Association of Cardiometabolic Disease With Cancer in the Community
Liu, E. E., Suthahar, N., Paniagua, S. M., Wang, D., Lau, E. S., Li, S. X., Jovani, M., Takvorian, K. S., Kreger, B. E., Benjamin, E. J., et al. (2022) · JACC CardioOncology · doi:10.1016/j.jaccao.2022.01.095 · Cited by 39
Khaldi, R. A., Al‐Mulla, F., Awadhi, S. A., Kapila, K., & Mojiminiyi, O. A. (2011) · Disease Markers · doi:10.1155/2011/832165 · Cited by 39
The role of dietary factors in the epidemiology of non-Hodgkin's lymphoma
Cross, A. J., & Lim, U. (2006) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190600932927 · Cited by 39
Dalamaga, Μ., Crotty, B. H., Fargnoli, J. L., Papadavid, E., Lekka, A., Triantafilli, M., Καρμανιώλας, Κ., Migdalis, I. N., Dionyssiou‐Asteriou, A., & Mantzoros, C. S. (2010) · Cancer Causes & Control · doi:10.1007/s10552-010-9573-y · Cited by 39
Mueller, N. E., & Grufferman, S. (2006) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195149616.003.0045 · Cited by 39
The association between obesity and the progression of prostate and renal cell carcinoma
Amling, C. L. (2004) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2004.10.004 · Cited by 39
HCC and NASH: How strong is the clinical demonstration?
Rosmorduc, O., & Fartoux, L. (2012) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2011.12.011 · Cited by 38
Obesity as a tumour development triggering factor
Budny, A., Grochowski, C., Kozłowski, P., Kolak, A., Kamińska, M., Kukiełka-Budny, B., Abramiuk, M., & Burdan, F. (2019) · Annals of Agricultural and Environmental Medicine · doi:10.26444/aaem/100664 · Cited by 38
Hepatitis C virus-associated insulin resistance: pathogenic mechanisms and clinical implications
Hung, C., Lee, C., & Lu, S. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.33 · Cited by 38
Energy Balance, the PI3K-AKT-mTOR Pathway Genes, and the Risk of Bladder Cancer
Lin, J. M., Wang, J., Greisinger, A. J., Grossman, H. B., Forman, M. R., Dinney, C. P., Hawk, E. T., & Wu, X. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0263 · Cited by 38
Freeman, H. J. (2004) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2004.07.002 · Cited by 38
Interaction between obesity-susceptibility loci in chromosome regions 2p25-p24 and 13q13-q21
Dong, C., Li, W., Li, D., & Price, R. A. (2004) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201292 · Cited by 37
Overweight and obesity in adults and risk of renal cell carcinoma in Canada
Hu, J., Mao, Y., & White, K. (2003) · Sozial- und Präventivmedizin · doi:10.1007/s00038-003-2046-2 · Cited by 37
Huang, J., Chan, S. C., Fung, Y. C., Mak, F. Y., Lok, V., Zhang, L., Xu, L., Lucero‐Prisno, D. E., Xu, W., Zheng, Z., et al. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.05.043 · Cited by 36
Fryzek, J. P., Schenk, M., Kinnard, M. F., Greenson, J. K., & Garabrant, D. H. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi183 · Cited by 36
Modesitt, S. C., Geffel, D. L., Via, J., & WELTMAN, A. L. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.11.013 · Cited by 35
Abdo, A. A., Hassanain, M. M., Aljumah, A. A., Olayan, A. A., Sanai, F. M., Alsuhaibani, H., AbdulKareem, H., Abdallah, K., AlMuaikeel, M., Saghier, M. A., et al. (2012) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2012.174 · Cited by 35
Insulin resistance in relation to melanoma risk
Antoniadis, A. G., Petridou, E. T., Antonopoulos, C. N., Dessypris, N., Panagopoulou, P., Chamberland, J. P., Adami, H., Gogas, H. J., & Mantzoros, C. S. (2011) · Melanoma Research · doi:10.1097/cmr.0b013e32834b0eeb · Cited by 35
Self-citationVogtmann, E., Li, H., Shu, X., Chow, W., Ji, B.-T., Cai, H., Gao, J., Zhang, W., Gao, Y., Zheng, W., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds287 · Cited by 35
Obesity, Physical Activity and Bladder Cancer
Noguchi, J. L., Liss, M. A., & Parsons, J. K. (2015) · Current Urology Reports · doi:10.1007/s11934-015-0546-2 · Cited by 34
Hospital‐diagnosed overweight and obesity related to cancer risk: a 40‐year Danish cohort study
Gribsholt, S. B., Cronin-Fenton, D. P., Veres, K., Thomsen, R. W., Ording, A. G., Richelsen, B., & Sørensen, H. T. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13013 · Cited by 34
Anthropometric measures and bladder cancer risk: A prospective study in the EPIC cohort
Roswall, N., Freisling, H., Bueno-de-Mesquita, H. B., Ros, M. M., Christensen, J., Overvad, K., Boutron‐Ruault, M., Severi, G., Fagherazzi, G., Chang-Claude, J. C., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28936 · Cited by 34
Okamura, Y., Maeda, A., Matsunaga, K., Kanemoto, H., & Uesaka, K. (2011) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1007/s00534-011-0461-y · Cited by 34
Epidemiology of Hepatocellular Carcinoma
White, D. L., Firozi, A., & El‐Serag, H. B. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-376-3_1 · Cited by 34
Prevalence of Cancer in Italian Obese Patients Referred for Bariatric Surgery
Boru, C. E., Silecchia, G., Pecchia, A., Iacobellis, G., Greco, F., Rizzello, M., & Basso, N. (2005) · Obesity Surgery · doi:10.1381/0960892055002284 · Cited by 33
Molecular Mechanisms Regulating Obesity-Associated Hepatocellular Carcinoma
Rajesh, Y., & Sarkar, D. (2020) · Cancers · doi:10.3390/cancers12051290 · Cited by 33
Environmental factors and risk of pancreatic cancer
Lowenfels, A. B., Maisonneuve, P., Khan, S. A., Beck, A. J., Carmichael, P. L., & Taylor-Robinson, S. D. (2003) · Pancreatology · doi:10.1159/000069140 · Cited by 33
Leptin inhibits hepatocellular carcinoma proliferation via p38-MAPK-dependent signalling
Thompson, K. J., Lau, K. N., Johnson, S., Martinie, J. B., Iannitti, D. A., McKillop, I. H., & Sindram, D. (2011) · HPB · doi:10.1111/j.1477-2574.2010.00259.x · Cited by 32
Metadata
- Authors
- Wolk, A., Gridley, G., Svensson, M., Nyrén, O., McLaughlin, J. K., Fraumeni, J. F., & Adami, H.-O.
- Affiliations
- Karolinska Institutet (SE)
- National Cancer Institute (US)
- International Epidemiology Institute (US)
- Corresponding author
- Wolk, Alicja
- Venue
- Cancer Causes & Control
- Published
- 2001-01
- Volume
- 12
- Issue
- 1
- Pages
- 13-21
- ISSN
- 0957-5243 (ISSN-L)
- 1573-7225
- OpenAlex
- W1522687886
- Cited by
- 581
- References
- 77
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 6 · 2023: 8 · 2022: 14 · 2021: 9 · 2020: 21 · 2019: 19 · 2018: 19 · 2017: 13 · 2016: 23 · 2015: 29 · 2014: 33 · 2013: 40 · 2012: 44
- FWCI
- 7.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Cancer Causes & Control (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01cp085636-006008)
- National Cancer Institute (N01-CP-85636)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Keywords
- obesity, cancer risk, cancer incidence, standardized incidence ratio, small intestine neoplasms, colon cancer, gallbladder cancer, pancreatic cancer, laryngeal cancer, bladder cancer, cervical cancer, endometrial cancer, ovarian cancer, brain cancer, Hodgkin's disease, non-Hodgkin lymphoma, breast cancer, prostate cancer
- MeSH terms
- Adolescent, Adult, Female, Follow-Up Studies, Humans, Male, Middle Aged, Neoplasms, Obesity, Patient Discharge, Population Surveillance, Registries, Risk Factors, Sweden, Comorbidity, Incidence, Prevalence, Sex Distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review